On June, 13 Pharma-Bio Serv, Inc. (PBSV) Analysts See $-0.01 EPS

May 17, 2018 - By Richard Doty

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Corporate Logo

Investors wait Pharma-Bio Serv, Inc. (OTCMKTS:PBSV)’s quarterly earnings on June, 13., as reported by RTT. The EPS diference is $0.00 or 0.00 % from last years number. Previous year: $-0.01; Analysts forcast: $-0.01. Lastly it traded at $0.6.It’s since May 17, 2017 and is 0.00% down. PBSV underperformed the S&P 500 by 11.55%.

Pharma-Bio Serv, Inc., a compliance and technology transfer services consulting company, provides compliance consulting services to the pharmaceutical, biotechnology, medical device, and chemical manufacturing companies in Puerto Rico, the United States, Europe, and Brazil.The firm is valued at $13.84 million. The companyÂ’s technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support.Last it reported negative earnings. It also provides microbiological testing services and chemical testing services through its laboratory; and technical trainings/seminars.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: